Currently Enrolling Trials

A Phase 4, Open-Label, Single-Group, Multicenter Study

in Adult Participants with Chronic Inflammatory 

Demyelinating Polyneuropathy Who Transition from 

Treatment with Intravenous Immunoglobulin to 

Efgartigimod PH20 SC

 Clinicaltrials.gov Listing

 A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Clinicaltrials.gov  Listing

 A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 

 Study Details | Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) | ClinicalTrials.gov 

 Study Details | A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation | ClinicalTrials.gov 

 Study Details | Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis | ClinicalTrials.gov 

 Study Details | Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis | ClinicalTrials.gov 

Study investigating a new formulation of subcutaneous Ocrelizumab